Profit Plummets 70% but Outlook Improves: easyJet Navigates Between Iran Conflict and EU Regulations, Acquisition Uncertainty Drives Stock Movements

智通财经2026/07/23 14:26

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

EasyJet's pre-tax profit for the third quarter plummeted 70% year-on-year to £85 million, far below the £286 million for the same period last year. The main reason was the Iran conflict causing sharp fuel price volatility and weakening passenger travel demand. However, this performance still exceeded expectations from analysts at JPMorgan and Royal Bank of Canada.
Against the backdrop of a profit slump, the share price rebounded nearly 6% on Thursday, partially recovering the 12% drop on Wednesday caused by reports the EU might tighten airline ownership rules. This suggests that while the market is digesting fundamental negatives, it is also reassessing the acquisition's prospects.
Company management stated that consumer confidence is strengthening with the arrival of the summer peak season in the Northern Hemisphere. There is strong booking demand close to travel dates, and the peak season seat occupancy rate gap is narrowing, indicating the operating environment is gradually improving.
On the acquisition front, bidder Castlelake must submit a formal offer by August 3 or withdraw, while Apollo's deadline is August 7 but it has yet to clarify how it will meet EU ownership requirements. Previously, EasyJet had supported Apollo's £5.7 billion takeover proposal.
Regulatory uncertainty brought by EU scrutiny has become the largest short-term variable. Analysts believe that if a European airline joins the bidding, it may help with review approval, even though it could attract tighter competition oversight. Overall, however, industry capacity consolidation is seen as a positive development.
From an airline sector perspective, EasyJet's predicament reflects common challenges faced by European low-cost carriers—geopolitical conflict driving up fuel costs, regulatory barriers raising M&A thresholds, and increasingly cautious consumer behavior. The final outcome of the acquisition contest will be an important catalyst for the sector's valuation reassessment.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AstraZeneca (AZN.US) has announced the termination of its clinical trial for the experimental drug volrustomig, after recent data indicated that the drug does not appear to provide superior results to existing therapies in lung cancer treatment. The latest update from AstraZeneca’s eVOLVE-Lung02 phase III clinical trial showed that volrustomig was not more effective than the blockbuster drug Keytruda in treating patients with low PD-L1 expression metastatic non-small cell lung cancer. Both drug

智通财经•2026/08/17 06:56

Rate hike expectations ease, US dollar approaches over two-month low, gold prices edge higher on Monday

智通财经•2026/08/17 06:56

Haitong International has released a research report stating that, in the current fragmented content market flooded by AI-generated content, Bilibili's content value is increasingly prominent. It is one of the few mid- to long-form video platforms that can still maintain user growth. The robust content ecosystem is expected to drive strong growth in advertising, and coupled with steady user traffic increases, has become the platform’s competitive advantage. The firm believes Bilibili’s current

智通财经•2026/08/17 06:46